Tag Archives: Single Source Off Patent Drugs

David Brushwood Interview — Podcast May 1, 2017

Martin Shkreli Isn’t the Only Profiteer in the Pharmaceutical Industry: Why Does the U.S., Alone Among Developed Countries, Allow Life-Saving Prescription Drugs To Be Priced Beyond the Reach Of Many Of the Patients Who Need Them? David Brushwood, professor emeritus of Pharmaceutical Outcomes … Continue reading →

Posted in Affordable Care Act, Corruption, Health Care, Health Care Delivery, Health Care Policy, Health Insurance, Interviews, Medicaid, Medicare, National Politics, Pharmaceutical Pricing and Procurement, Podcasts, Public Health Policy | Tagged , , , , , , , , , , , , , , , , , , , | Comments Off on David Brushwood Interview — Podcast May 1, 2017